Exam (elaborations)

TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 5TH EDITION WOO ROBINSON

0 purchase

Course
Health Care

Institution
Chamberlian School Of Nursing

TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 5TH EDITION WOO ROBINSONContents Chapter 1. The Role of the Nurse Practitioner ...........................................................................................................2 Chapter 2. Review of Basic Principles o...

[Show more]

Preview 4 out of 196 pages

View example

Uploaded on January 10, 2024
Number of pages 196
Written in 2023/2024
Type Exam (elaborations)
Contains Questions & answers

test bank

Expert001 Member since 3 year 691 documents sold

$15.49

Add to cart

Add to wishlist

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th
Edition Woo Robinson Test Bank
Contents
Chapter 1. The Role of the Nurse Practitioner ...........................................................................................................2
Chapter 2. Review of Basic Principles of Pharmacology............................................................................................3
Chapter 3. Rational Drug Selection .........................................................................................................................10
Chapter 4. Legal and Professional Issues in Prescribing .........................................................................................12
Chapter 5. Adverse Drug Reactions ........................................................................................................................14
Chapter 6. Pharmacoeconomics .............................................................................................................................17
Chapter 7. Nutrition and Nutraceuticals ...................................................................................................................19
Chapter 8. Herbal Therapy and Nutritional Supplements.........................................................................................25
Chapter 9. Informatics .............................................................................................................................................27
Chapter 10. Pharmacoeconomics ...........................................................................................................................31
Chapter 11. Drugs Affecting the Autonomic Nervous System ..................................................................................33
Chapter 12. Drugs Affecting the Central Nervous System .......................................................................................40
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ......................................................................48
Chapter 14. Drugs Affecting the Respiratory System ..............................................................................................56
Chapter 15. Drugs Affecting the Hematological System ..........................................................................................60
Chapter 16. Drugs Affecting the Immune System ....................................................................................................63
Chapter 17. Drugs Affecting the Gastrointestinal System ........................................................................................67
Chapter 18. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ........................69
Chapter 19. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ....................................73
Chapter 20. Drugs Affecting the Reproductive System ............................................................................................85
Chapter 21. Drugs Affecting the Bones and Joints ..................................................................................................89
Chapter 22. Drugs Affecting the Integumentary System ..........................................................................................95
Chapter 23. Drugs Used in Treating Bacterial Diseases ..........................................................................................99
Chapter 24. Drugs Used to Treat Viral, Fungal, and Protozoal Infections .............................................................104
Chapter 25. Drugs Used in Treating Inflammatory Processes ...............................................................................108
Chapter 26. Drugs Used in Treating Eye and Ear Disorders ..................................................................................111
Chapter 27. Alcohol and Drug Addiction................................................................................................................113
Chapter 28. Anemia ..............................................................................................................................................118
Chapter 29. Angina ...............................................................................................................................................120
Chapter 30. Anxiety and Depression .....................................................................................................................124
Chapter 31. Attention Deficit Hyperactivity Disorder ..............................................................................................126
Chapter 32. Asthma and Chronic Obstructive Pulmonary Disease ........................................................................129
Chapter 33. Contraception ....................................................................................................................................131

1|Page

,Chapter 34. Dermatologic Conditions ....................................................................................................................133
Chapter 35. Diabetes Management .......................................................................................................................136
Chapter 35 DiabetesManagement .........................................................................................................................142
Chapter 36. Gastroesophageal Reflux and Peptic Ulcer Disease ..........................................................................144
Chapter 37. Headaches ........................................................................................................................................146
Chapter 38. Heart Failure ......................................................................................................................................149
Chapter 39. Human Immunodeficiency Virus Disease and Acquired Immunodeficiency Syndrome .......................152
Chapter 40. Hormone Replacement Therapy ........................................................................................................155
Chapter 41. Hyperlipidemia ...................................................................................................................................158
Chapter 42. Hypertension......................................................................................................................................161
Chapter 43. Hyperthyroidism and Hypothyroidism .................................................................................................164
Chapter 44. Pain Management: Acute and Chronic Pain ......................................................................................167
Chapter 45. Pneumonia ........................................................................................................................................170
Chapter 46. Smoking Cessation ............................................................................................................................171
Chapter 47. Sexually Transmitted Infections and Vaginitis ....................................................................................174
Chapter 48. Tuberculosis ......................................................................................................................................177
Chapter 49. Upper Respiratory Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ..........................178
Chapter 50. Urinary Tract Infections ......................................................................................................................181
Chapter 51: Women as Patients ............................................................................................................................183
Chapter 52. Men as Patients .................................................................................................................................186
Chapter 53. Pediatric Patients ...............................................................................................................................188
Chapter 54. Transgendered Clients as Patients ....................................................................................................190
Chapter 55. Geriatric Patients ...............................................................................................................................192
Overview ...............................................................................................................................................................196

Chapter 1. The Role of the Nurse Practitioner
Multiple Choice
Identify the choice that best completes the statement or answers the question.

1. Nurse practitioner prescriptive authority is regulated by:
1. The National Council of State Boards of Nursing
2. The U.S. Drug Enforcement Administration
3. The State Board of Nursing for each state
4. The State Board of Pharmacy
2. The benefits to the patient of having an Advanced Practice Registered Nurse (APRN)
prescriberinclude:
1. Nurses know more about Pharmacology than other prescribers because they
take itboth in their basic nursing program and in their APRN program.
2|Page

, 2. Nurses care for the patient from a holistic approach and include the patient
indecision making regarding their care.
3. APRNs are less likely to prescribe narcotics and other controlled substances.
4. APRNs are able to prescribe independently in all states, whereas a physician’s
assistant needs to have a physician supervising their practice.

3. Clinical judgment in prescribing includes:
1. Factoring in the cost to the patient of the medication prescribed
2. Always prescribing the newest medication available for the disease process
3. Handing out drug samples to poor patients
4. Prescribing all generic medications to cut costs
4. Criteria for choosing an effective drug for a disorder include:
1. Asking the patient what drug they think would work best for them
2. Consulting nationally recognized guidelines for disease management
3. Prescribing medications that are available as samples before writing a prescription
4. Following U.S. Drug Enforcement Administration guidelines for prescribing

5. Nurse practitioner practice may thrive under health-care reform because of:
1. The demonstrated ability of nurse practitioners to control costs and improve
patientoutcomes
2. The fact that nurse practitioners will be able to practice independently
3. The fact that nurse practitioners will have full reimbursement under health-
carereform
4. The ability to shift accountability for Medicaid to the state level

Chapter 1. The Role of the Nurse Practitioner Answer Section

MULTIPLE CHOICE

1. ANS: 3 PTS: 1
2. ANS: 2 PTS: 1
3. ANS: 1 PTS: 1
4. ANS: 2 PTS: 1
5. ANS: 1 PTS: 1

Chapter 2. Review of Basic Principles of

Pharmacology
Multiple Choice
Identify the choice that best completes the statement or answers the question.

1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to
prescribing because:
1. Distribution of drugs to target tissue may be affected.
2. The solubility of the drug will not match the site of absorption.
3. There will be less free drug available to generate an effect.
4. Drugs bound to albumin are readily excreted by the kidneys.
3|Page

, 2. Drugs that have a significant first-pass effect:
1. Must be given by the enteral (oral) route only
2. Bypass the hepatic circulation
3. Are rapidly metabolized by the liver and may have little if any desired action
4. Are converted by the liver to more active and fat-soluble forms
3. The route of excretion of a volatile drug will likely be the:
1. Kidneys
2. Lungs
3. Bile and feces
4. Skin
4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly (IM) to create a
storagereservoir of the drug. Storage reservoirs:
1. Assure that the drug will reach its intended target tissue
2. Are the reason for giving loading doses
3. Increase the length of time a drug is available and active
4. Are most common in collagen tissues

5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
1. Propensity to go to the target receptor
2. Biological half-life
3. Pharmacodynamics
4. Safety and side effects
6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
prescription. This is considered a loading dose. A loading dose:
1. Rapidly achieves drug levels in the therapeutic range
2. Requires four- to five-half-lives to attain
3. Is influenced by renal function
4. Is directly related to the drug circulating to the target tissues
7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic
effectis the:
1. Minimum adverse effect level
2. Peak of action
3. Onset of action
4. Therapeutic range

8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done:
1. When the drug has a wide therapeutic range
2. When the drug will be administered for a short time only
3. When there is a high correlation between the dose and saturation of receptor sites
4. To determine if a drug is in the therapeutic range
9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration.
This means that the:
1. Concentration will produce therapeutic effects
2. Concentration will produce an adverse response
3. Time between doses must be shortened
4. Duration of action of the drug is too long
4|Page

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Expert001. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $15.49. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

69252 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling

Exam (elaborations)

TEST BANK PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 5TH EDITION WOO ROBINSON

Document information

Subjects

Written for

Seller

Reviews received

Content preview